Reuters
Reuters
@Reuters·4.2M subscribers·81.1K videos

GSK sees sales growth in 2022 after quarterly beat, prepares for spin-off

Posted

February 9, 2022

Views

587

Likes

2

Engagement

0.34%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

GSK racked up $1.9 billion in COVID-related sales in 2021, beating quarterly forecasts in its first earnings report since rejecting Unilever's bid for its consumer arm.

#GSK #COVID #News #Reuters

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on

Follow Reuters on Facebook

Follow Reuters on Twitter

Follow Reuters on Instagram

Guests & Subjects Covered

Follow ReutersFacebook Follow ReutersTwitter Follow Reuters

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.